DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Single-Use Bio-Processing Systems Market, 2016 to 2023" report to their offering.
The market was valued at USD 1,946.7 Mn in 2015, and is expected to reach USD 19,059.3 Mn by 2023, expanding at a CAGR of 33.0% from 2016 to 2022.
The Global Single-use Bio-processing Systems market is expected to witness significant growth during the forecast period primarily by the growing demand and cost- effective features of these single-use systems, which are mostly used in R&D applications. The essential bio-processing systems used in R&D applications are disposable bioreactors, mixers, containers, tubing, connectors, sampling systems, purification devices and columns, and probes/sensors. The overall market has also undergone a paradigm shift owing to the growing usage of GMP single-use systems and the increasing outsourcing activities to the developing nations.
North America held the largest regional market, accounting for the market share of over 35% in 2015, and is expected to dominate the global single-user bio-processing systems market during the forecast period of 2016 to 2022. The prime factors driving the market are adoption of cost-cutting practices by biopharmaceutical companies. and the increasing prevalence of diseases leading to the procurement of biologics and biopharmaceuticals.
Companies Mentioned
- GE Healthcare
- Merck & Co.
- Santorius
- Broadly-James
- Cellexus
- Thermo Fisher Scientific
- Eppendorf
- Finesse Solutions
- Parker Hannifin
-
Saint-Gobain
Key Topics Covered:
Chapter 1 Preface
Chapter 2 Executive Summary
Chapter 3 Single-Use Bio-Processing Systems: Market Dynamics and Outlook
Chapter 4 Single-Use Bio-Processing Systems Market, by Treatments
Chapter 5 Single-Use Bio-Processing Systems Market, by Geography
Chapter 6 Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/z4xv5n/global_singleuse
